MeiraGTx (MGTX) CMO vests 17,500 RSUs, withholds 6,729 shares for taxes

Rhea-AI Filing Summary

MeiraGTx Holdings plc Chief Medical Officer Robert K. Zeldin filed a Form 4 showing routine equity compensation activity. On January 7, 2026, 17,500 restricted share units granted on January 7, 2022 vested, with each unit converting into one ordinary share. To cover taxes on this vesting, 6,729 ordinary shares were withheld at a price of $7.73 per share rather than being sold in the open market.

After these transactions, Zeldin directly beneficially owned 147,291 ordinary shares of MeiraGTx. The filing reflects compensation-related vesting and associated tax withholding rather than discretionary market buying or selling.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zeldin Robert K

(Last) (First) (Middle)

450 EAST 29TH STREET

14TH FLOOR

(Street)

NEW YORK NY 10016

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MeiraGTx Holdings plc [ MGTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF MEDICAL OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
01/07/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	01/07/2026		M		17,500(1)	A	(2)	154,020	D
Ordinary Shares	01/07/2026		F		6,729(3)	D	$7.73	147,291	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Units	(2)	01/07/2026		M			17,500	(1)	(1)	Ordinary Shares	17,500	$0	0	D

Explanation of Responses:

1. Represents vesting of one-quarter of restricted share units granted on January 7, 2022.

2. Each restricted share unit converts into one ordinary share upon vesting.

3. Shares withheld for payment of taxes upon vesting of award.

	/s/ Robert J. Wollin, Attorney-in-fact for Robert K. Zeldin	01/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did MeiraGTx (MGTX) report in this Form 4?

The Form 4 reports that Chief Medical Officer Robert K. Zeldin had 17,500 restricted share units vest on January 7, 2026, which converted into ordinary shares, and a portion of those shares was withheld to cover taxes.

How many MeiraGTx restricted share units vested for the CMO and when?

17,500 restricted share units vested for Robert K. Zeldin on January 7, 2026. These units were originally granted on January 7, 2022, and represented one-quarter of that award.

How many MeiraGTx shares were withheld for taxes in this Form 4 filing?

The filing shows that 6,729 ordinary shares were withheld at a price of $7.73 per share to satisfy tax obligations arising from the vesting of the restricted share units.

What is Robert K. Zeldin’s MeiraGTx share ownership after these transactions?

Following the vesting and tax withholding transactions, Robert K. Zeldin directly beneficially owned 147,291 ordinary shares of MeiraGTx Holdings plc.

Were the MeiraGTx insider transactions open-market trades?

No. The Form 4 indicates a code M transaction for the conversion of restricted share units into ordinary shares and a code F transaction for shares withheld to pay taxes, rather than discretionary open-market purchases or sales.

What do the MeiraGTx restricted share unit footnotes explain?

The footnotes state that the 17,500 units represent one-quarter of an award granted on January 7, 2022, that each restricted share unit converts into one ordinary share upon vesting, and that the 6,729 shares were withheld solely to pay taxes on the vesting.